Zika virus outbreak and the case for building effective and sustainable rapid diagnostics laboratory capacity globally

• Alimuddin Zumla,
• Ian Goodfellow,
• Francis Kasolo,
• Francine Ntoumi,
• Philippe Buchy,
• Matthew Bates,
• Esam I Azhar,
• Matthew Cotten,
• Eskild Petersen

Affiliations

Alimuddin Zumla

Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCLHospitals NHS Foundation Trust, London, UK

Ian Goodfellow

Division of Virology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge UK and School of Public Health, University of Makeni, Sierra Leone

Francis Kasolo

Country and Inter-country Support, Office of the Regional Director, WHO- AFRO, Brazzaville, Republic of Congo

Francine Ntoumi

Fondation Congolaise pour la Recherche Médicale and University Marien Ngouabi, Brazzaville, Republic of Congo, and Institute for Tropical Medicine, University of Tübingen, Germany

Philippe Buchy

GlaxoSmithKline Vaccines, R&D Asia-Pacific, Gateway West, Singapore

Matthew Bates

UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia

Esam I Azhar

Special Infectious Agents Unit, King Fahd Medical Research Centre, and Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia

Matthew Cotten

The Wellcome Trust Sanger Institute, Cambridge, UK

Eskild Petersen

University of Aarhus, Denmark and The Royal Hospital, Muscat, Oman